HBM Partners
47
27M
36
2.04
6
0.21
16
- Stages of investment
- Areas of investment
Summary
HBM Partners is the famous VC, which was founded in 2001. The venture was found in North America in Cayman Islands. The main department of described VC is located in the Grand Cayman.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the HBM Partners, startups are often financed by InterWest Partners, HBM Healthcare Investments AG, Correlation Ventures. The meaningful sponsors for the fund in investment in the same round are InterWest Partners, Correlation Ventures, Advanced Technology Ventures. In the next rounds fund is usually obtained by Correlation Ventures, KfW, InterWest Partners.
We also calculated 4 valuable employees in our database.
We can highlight the next thriving fund investment areas, such as Health Diagnostics, Medical. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline ITeos Therapeutics, Iconic Therapeutics, Newron Pharmaceuticals The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
The fund is constantly included in less than 2 deals per year. This HBM Partners works on 13 percentage points more the average amount of lead investments comparing to the other organizations. The increased amount of exits for fund were in 2017. The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2004. Considering the real fund results, this VC is 3 percentage points less often commits exit comparing to other organizations.
Investments analytics
Analytics
- Total investments
- 47
- Lead investments
- 6
- Exits
- 16
- Rounds per year
- 2.04
- Follow on index
- 0.21
- Investments by industry
- Biotechnology (28)
- Health Care (23)
- Medical (19)
- Therapeutics (10)
- Pharmaceutical (10) Show 26 more
- Investments by region
-
- United States (25)
- Switzerland (4)
- Canada (2)
- Austria (2)
- Germany (6) Show 4 more
- Peak activity year
- 2023
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 16
- Avg. valuation at time of investment
- 81M
- Group Appearance index
- 0.62
- Avg. company exit year
- 9
- Avg. multiplicator
- 5.75
- Strategy success index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Genalyte | 07 Mar 2023 | Diagnostic Equipment, Biotechnology, Other Healthcare Technology Systems, Health Care, Hospital | Late Stage Venture | 1M | United States, California, San Diego |
Monte Rosa Therapeutics | 24 Sep 2020 | Biotechnology, Medical, Therapeutics | Early Stage Venture | 96M | Switzerland, Basel-City, Basel |
Whatfix | 10 Apr 2015 | Software, Information Technology, Information Services, Enterprise Software, Training, Enterprise Applications, Customer Service, Guides | Seed | 900K | United States, California, San Jose |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.